Correlation Between Nu Med and Talis Biomedical

Can any of the company-specific risk be diversified away by investing in both Nu Med and Talis Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nu Med and Talis Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nu Med Plus and Talis Biomedical Corp, you can compare the effects of market volatilities on Nu Med and Talis Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nu Med with a short position of Talis Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nu Med and Talis Biomedical.

Diversification Opportunities for Nu Med and Talis Biomedical

0.58

Correlation Coefficient

Nu Med  Talis Biomedical

Very weak diversification

The 3 months correlation between NUMD and Talis is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Nu Med Plus and Talis Biomedical Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Talis Biomedical Corp and Nu Med is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nu Med Plus are associated (or correlated) with Talis Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Talis Biomedical Corp has no effect on the direction of Nu Med i.e., Nu Med and Talis Biomedical go up and down completely randomly.

Pair Corralation between Nu Med and Talis Biomedical

Given the investment horizon of 90 days Nu Med Plus is expected to generate 1.78 times more return on investment than Talis Biomedical. However, Nu Med is 1.78 times more volatile than Talis Biomedical Corp. It trades about 0.07 of its potential returns per unit of risk. Talis Biomedical Corp is currently generating about -0.11 per unit of risk. If you would invest  1.80  in Nu Med Plus on October 5, 2024 and sell it today you would lose (0.26) from holding Nu Med Plus or give up 14.44% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	69.66%
Values	Daily Returns

Nu Med Plus  vs.  Talis Biomedical Corp

Nu Med Plus

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Nu Med Plus has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Talis Biomedical Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Talis Biomedical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable forward indicators, Talis Biomedical is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Nu Med and Talis Biomedical

The main advantage of trading using opposite Nu Med and Talis Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nu Med position performs unexpectedly, Talis Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Talis Biomedical will offset losses from the drop in Talis Biomedical's long position.

The idea behind Nu Med Plus and Talis Biomedical Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.